BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21185077)

  • 1. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
    Cetin I; Huppertz B; Burton G; Cuckle H; Gonen R; Lapaire O; Mandia L; Nicolaides K; Redman C; Soothill P; Spencer K; Thilaganathan B; Williams D; Meiri H
    Placenta; 2011 Feb; 32 Suppl():S4-16. PubMed ID: 21185077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of early non-invasive markers and means for the diagnosis and progression monitoring of preeclampsia and tailoring putative therapies (project pregenesys 037244).
    Meiri H; Huppertz B; Cetin I
    Placenta; 2011 Feb; 32 Suppl():S1-3. PubMed ID: 21257078
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic assessment of screening for pre-eclampsia.
    Shmueli A; Meiri H; Gonen R
    Prenat Diagn; 2012 Jan; 32(1):29-38. PubMed ID: 22234821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction and prevention of pre-eclampsia.
    Leslie K; Thilaganathan B; Papageorghiou A
    Best Pract Res Clin Obstet Gynaecol; 2011 Jun; 25(3):343-54. PubMed ID: 21376671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minutes of the 1st national symposium on hypertensive disorders in pregnancy].
    Yang Z; Lin JH; Feng SL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):84-6. PubMed ID: 19570414
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction and prevention of preeclampsia and IUGR.
    Fayyad AM; Harrington KF
    Early Hum Dev; 2005 Nov; 81(11):865-76. PubMed ID: 16289644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers in pre-eclampsia.
    Kharb S
    Biomarkers; 2009 Sep; 14(6):395-400. PubMed ID: 19552567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary.
    Copel JA; Platt LD; Hobbins JC; Afshar Y; Grechukhina O; Mallampati D; Bromley B; Caughey AB; Grobman W; Han CS; Nicolaides K; Pettker C; Saade G; Sibai B; Simhan H; Sonek J; Werner E; Chescheir N
    Obstet Gynecol; 2020 Jan; 135(1):36-45. PubMed ID: 31809427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia and future cardiovascular risk.
    Newstead J; von Dadelszen P; Magee LA
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):283-94. PubMed ID: 17338672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, prevention, and management of eclampsia.
    Sibai BM
    Obstet Gynecol; 2005 Feb; 105(2):402-10. PubMed ID: 15684172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preeclampsia prevention and management.
    Norwitz ER; Repke JT
    J Soc Gynecol Investig; 2000; 7(1):21-36. PubMed ID: 10732313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and risk factors of pre-eclampsia.
    Kaaja R
    Minerva Ginecol; 2008 Oct; 60(5):421-9. PubMed ID: 18854808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preeclampsia.
    Smith MA
    Prim Care; 1993 Sep; 20(3):655-64. PubMed ID: 8378457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of hypertensive disorders of pregnancy 2008.
    Lowe SA; Brown MA; Dekker GA; Gatt S; McLintock CK; McMahon LP; Mangos G; Moore MP; Muller P; Paech M; Walters B;
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):242-6. PubMed ID: 19566552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factors and pre-eclampsia: an early marker is needed.
    Stepan H
    Clin Sci (Lond); 2009 Feb; 116(3):231-2. PubMed ID: 19032146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New markers in preeclampsia.
    Hertig A; Liere P
    Clin Chim Acta; 2010 Nov; 411(21-22):1591-5. PubMed ID: 20659441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.